Previous close | 230.71 |
Open | 232.24 |
Bid | 234.34 x 800 |
Ask | 234.57 x 900 |
Day's range | 231.13 - 236.09 |
52-week range | 188.10 - 255.93 |
Volume | |
Avg. volume | 473,566 |
Market cap | 23.513B |
Beta (5Y monthly) | 0.66 |
PE ratio (TTM) | 94.69 |
EPS (TTM) | 2.48 |
Earnings date | 08 Aug 2022 - 12 Aug 2022 |
Forward dividend & yield | 1.72 (0.75%) |
Ex-dividend date | 13 Jun 2022 |
1y target est | 263.80 |
Investors are optimistic about STERIS (STE) due to its strong fiscal fourth-quarter results.
Robust performances across all four reporting segments drive STERIS' (STE) fiscal fourth-quarter revenues.
Fourth quarter revenue increases 39% as reported; 11% constant currency organicAs reported EPS of $0.52; adjusted EPS of $2.04Company provides FY23 outlook DUBLIN, IRELAND, May 11, 2022 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2022 fourth quarter ended March 31, 2022. Revenue as reported for the quarter increased 39% to $1.2 billion compared with $873.5 million in the fourth quarter of fiscal 2021. Constant currency o